Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of rimonabant on energy expenditure and fat metabolism in obesity
2006-006424-18Phase 4Terminated
- Sponsor
- University of Surrey
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of rimonabant in obesity, sponsored by University of Surrey. Primary endpoint: Total energy expenditure. Started Jan 2007; status: terminated.
02
Drugs
rimonabant
03
Conditions
obesity
Beyond the preview
Go deeper on 2006-006424-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006424-18.